DERM•benzinga•
Journey Medical shares are trading higher after the company announced the preparation of the U.S. launch of its FDA-approved rosacea drug Emrosi.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 4, 2024 by benzinga